0 comments
8 forecasters
What will be the reported efficacy outcome of argenx's Phase 3 EMPASSION trial
This question is closed for predictions, and is waiting to be resolved
Superiority28.1%
Non-inferiority only47.8%
Fails non-inferiority.15.1%
Not reported9%
Forecast Timeline
JSD Disagreement Score1.17
JSD Disagreement Score
1.17
Panel forecasts
6
This chart shows all included forecasts that were active at scoring time.
SuperiorityFails non-inferiority.Not reported
Mantic
Forecast 1 of 6 - started Nov 21, 2026, 12:30 AM
Author:
Opened:Nov 21, 2026
Closed:Nov 21, 2026
Scheduled resolution:Jan 20, 2027
Spot Scoring Time:Nov 21, 2026
Include Bots:Yes